Jun 24, 2026
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.10 to $1.00.
The split itself did not change the total investment value.
BLS Pharmaceuticals Limited (ASX:BLS) operates in the Miscellaneous commercial services industry.
BLS Pharmaceuticals Limited company overviewBLS Pharmaceuticals Limited's most recent stock split was on June 24, 2026. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
BLS Pharmaceuticals Limited (ASX:BLS) has split its stock 3 times: a 1-for-20 reverse split on March 19, 2012, a 10-for-7 split on May 11, 2017, and a 1-for-10 reverse split on June 24, 2026.
BLS Pharmaceuticals Limited has split its stock 3 times. This history records 3 splits between March 19, 2012 and June 24, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In BLS Pharmaceuticals Limited's 1-for-10 reverse split on June 24, 2026, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
BLS Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on June 24, 2026, less than a year ago. Companies announce splits in advance, and any new ASX:BLS split will appear on this page.
Already premium?